ENTRY       D05266                      Drug
NAME        Oprelvekin (USAN/INN);
            Oprelvekin (genetical recombination) (JAN);
            Neumega (TN)
FORMULA     C854H1411N253O235S2
EXACT_MASS  19035.5679
MOL_WEIGHT  19047.0252
SEQUENCE    GPPPGPPRVS PDPRAELDST VLLTRSLLAD TRQLAAQLRD KFPADGDHNL DSLPTLAMSA
            GALGALQLPG VLTRLRADLL SYLRHVQWLR RAGGSSLKTL EPELGTLQAR LDRLLRRLQL
            LMSRLALPQP PPDPPAPPLA PPSSAWGGIR AAHAILGGLH LTLDWAVRGL LLLKTRL
  TYPE      Peptide
REMARK      ATC code: L03AC02
EFFICACY    Immunostimulant
COMMENT     recombinant human interleukin-11
            Hematopoietic stimulant
TARGET      IL11RA [HSA:3590] [KO:K05056]
  PATHWAY   hsa04060(3590)  Cytokine-cytokine receptor interaction
            hsa04630(3590)  JAK-STAT signaling pathway
            hsa04640(3590)  Hematopoietic cell lineage
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AC Interleukins
                 L03AC02 Oprelvekin
                  D05266  Oprelvekin (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL11RA
                 D05266  Oprelvekin (USAN/INN)
DBLINKS     CAS: 145941-26-0
            PubChem: 47206975
///
